Antinuclear antibodies and propylthiouracil therapy.
D000974:Antibodies, Antinuclear; D000917:Antibody Formation / Q000187:drug effects; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008297:Male; D011441:Propylthiouracil / Q000009:adverse effects / Q000627:therapeutic use*
D000974:Antibodies, Antinuclear; D011441:Propylthiouracil